Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02622945
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
R23 | METHYL-[4-(4-PIPERIDINE-1-YLMETHYL- PHENYL)-CYCLOHEXYL]-CARBAMINIC ACID- (4-CHLOROPHENYL)-ESTER | A,B,C | 1O79 | 0.72 | |
GVB | (3R,4S)-1-(3,4-DIMETHOXYPHENYL)- 3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE | A,B | 2JID | 0.71 | |
LO2 | 2-{4-[butyl(3-chloro-4,5-dimethoxybenzyl)amino]phenyl}- 1,1,1,3,3,3-hexafluoropropan-2- ol | A,B,C,D | 3FAL | 0.73 | |
UC1 | 2-METHYL-FURAN-3-CARBOTHIOIC ACID [4- CHLORO-3-(3-METHYL-BUT-2-ENYLOXY)- PHENYL]-AMIDE | A | 1JLG | 0.71 | |
UC1 | 2-METHYL-FURAN-3-CARBOTHIOIC ACID [4- CHLORO-3-(3-METHYL-BUT-2-ENYLOXY)- PHENYL]-AMIDE | A | 1RT4 | 0.71 | |
UC1 | 2-METHYL-FURAN-3-CARBOTHIOIC ACID [4- CHLORO-3-(3-METHYL-BUT-2-ENYLOXY)- PHENYL]-AMIDE | A,B | 1S1T | 0.71 | |
UC1 | 2-METHYL-FURAN-3-CARBOTHIOIC ACID [4- CHLORO-3-(3-METHYL-BUT-2-ENYLOXY)- PHENYL]-AMIDE | A | 1S1W | 0.71 | |
GFA | 2-[4-chloro-2-(phenylcarbonyl)phenoxy]- N-phenylacetamide | A | 3DLE | 0.77 | |
BN3 | 4-[3-CHLORO-4-({[(2,4-DICHLOROBENZOYL)AMINO]CARBONYL}AMINO)PHENOXY]BUTANOIC ACID | A | 1WUY | 0.71 | |
L1R | 4-(2-AMINOETHOXY)-3,5-DICHLORO- N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE | A | 2VIP | 0.8 | |
BN2 | 7-[2,6-DICHLORO-4-({[(2-CHLOROBENZOYL)AMINO]CARBONYL}AMINO)PHENOXY]HEPTANOIC ACID | A | 1WUT | 0.76 | |
QUM | QUINACRINE MUSTARD | A,B | 1GXF | 0.76 | |
BN5 | 5-[3-({[(2,4-DICHLOROBENZOYL)AMINO]CARBONYL}AMINO)- 2-METHYLPHENOXY]PENTANOIC ACID | A | 1WV1 | 0.72 | |
617 | 2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID | A | 2QE5 | 0.72 | |
A6T | (1S,5R)-7-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}- N-cyclopropyl-N-(2,3-dichlorobenzyl)- 3,9-diazabicyclo[3.3.1]non-6-ene- 6-carboxamide | A,B | 3G72 | 0.71 | |
VG2 | 4-(2-aminoethoxy)-N-(3-chloro-5- piperidin-1-ylphenyl)-3,5-dimethylbenzamide | A | 2VIV | 0.8 | |
BN4 | 4-[4-({[(2,4-DICHLOROBENZOYL)AMINO]CARBONYL}AMINO)- 2,3-DIMETHYLPHENOXY]BUTANOIC ACID | A | 1WV0 | 0.71 | |
H12 | 6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN- 2(1H)-ONE | A | 1TKT | 0.76 | |
XNI | (11S)-10-acetyl-11-[4-(benzyloxy)- 3-chlorophenyl]-3,3-dimethyl-2,3,4,5,10,11- hexahydro-1H-dibenzo[b,e][1,4]diazepin- 1-one | A,B | 3CSO | 0.77 | |
JP1 | N-[3-CHLORO-4-(4-CHLORO-2-HYDROXYPHENOXY)PHENYL]MORPHOLINE- 4-CARBOXAMIDE | A,B | 1ZXL | 0.73 | |
B5R | (2S)-3-(4-chloro-3-fluorophenoxy)- N-[4-cyano-3-(trifluoromethyl)phenyl]- 2-hydroxy-2-methylpropanamide | A | 3B5R | 0.7 | |
A7T | (1R,5S)-N-cyclopropyl-7-{4-[2-(2,6- dichloro-4-methylphenoxy)ethoxy]phenyl}- N-(2,3-dimethylbenzyl)-3,9-diazabicyclo[3.3.1]non- 6-ene-6-carboxamide | A,B | 3G6Z | 0.72 | |
4BG | N-[4-(benzyloxy)phenyl]glycinamide | A | 3CHO | 0.76 | |
A5T | (1R,5S)-7-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}- N-cyclopropyl-N-(2,3-dichlorobenzyl)- 3,9-diazabicyclo[3.3.1]non-6-ene- 6-carboxamide | A,B | 3G70 | 0.71 | |
L05 | 1-BENZYL-3-(4-METHOXYPHENYLAMINO)- 4-PHENYLPYRROLE-2,5-DIONE | A,B,C,D,E,F, G,H | 2ACL | 0.74 | |
TF3 | N-(2-AMINOETHYL)-2-{3-CHLORO-4- [(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE | A | 2BU7 | 0.71 | |
433 | 2-(4-{3-[1-[2-(2-CHLORO-6-FLUORO- PHENYL)-ETHYL]-3-(2,3-DICHLORO- PHENYL)-UREIDO]-PROPYL}-PHENOXY)- 2-METHYL-PROPIONIC ACID | A,B | 1GWX | 0.71 | |
H20 | 6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN- 2(1H)-ONE | A | 1TL3 | 0.76 | |
ADB | 4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)- [1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE | A | 1S9E | 0.73 | |
4BS | 4-amino-N-[4-(benzyloxy)phenyl]butanamide | A | 3CHR | 0.76 | |
D56 | 4-(2-aminoethoxy)-N-(3-chloro-2- ethoxy-5-piperidin-1-ylphenyl)- 3,5-dimethylbenzamide | A | 2VIW | 0.79 | |
IC1 | 3-[(2,4,6-TRIMETHOXY-PHENYL)-METHYLENE]- INDOLIN-2-ONE | A,B | 1EH4 | 0.71 |